Epiphany News

      02/12/2008  Students test new mono treatment drug (The Minnesota Daily)

12/06/2007  Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis

11/07/2007  Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles

03/30/2007  Epiphany Biosciences, Inc. Announces Appointments to Its Board of Directors

03/15/2007  Epiphany Biosciences Raises $36 Million Round in Private Financing

02/22/2007  Michael Houghton, co-discoverer of Hepatitis C and Lasker Award Winner, to become Epiphany Biosciences’ Chief Scientific Officer

02/15/2007  2006 Nobel Laureate Roger Kornberg to Join Epiphany Biosciences’ Scientific Advisory Board

12/06/2006 Epiphany Biosciences Appoints Brian Murphy as Chief Medical Officer

09/08/2006 Epiphany Biosciences licenses antiviral compound EPB-348 (MIV-606) from Medivir AB